Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Asian J Psychiatr ; 57: 102563, 2021 Mar.
Article in English | MEDLINE | ID: covidwho-2304962

ABSTRACT

Patients hospitalized with COVID-19 are at risk of developing many neuropsychiatric disorders, due to the effects of the disease on the brain and the psychosocial pressures of having the disease. The aim of the present study was to evaluate the characteristics and outcomes of patients who were hospitalized with a diagnosis of COVID-19, who underwent psychiatric consultations. The medical records of 892 patients hospitalized due to COVID-19 and the 89 among them who requested psychiatric consultations were analyzed retrospectively. After the psychiatric consultations, patients were most frequently diagnosed with delirium (38.2 %), adjustment disorder (27.0 %), depressive disorder (19.1 %) and anxiety disorder (11.2 %). Patients with delirium had longer hospital stays (p < 0.001), were transferred more frequently to intensive care units (p < 0.001), and had higher mortality rates during their hospital stays (p < 0.001), than all other patients. The need for oxygen (p < 0.001) and mechanical ventilation (p < 0.001) was also significantly higher in delirium patients, as well as in patients who received other psychiatric diagnoses. Neuropsychiatric disorders develop in patients receiving inpatient treatments in COVID-19 wards, and these disorders negatively affect the prognosis of COVID-19. Our findings suggest that the presence of neuropsychiatric disorders in in-patients with COVID-19 might be associated with the negative outcomes of the disease.


Subject(s)
Adjustment Disorders/etiology , Anxiety Disorders/etiology , COVID-19/complications , COVID-19/therapy , Delirium/etiology , Depressive Disorder/etiology , Adjustment Disorders/diagnosis , Adult , Aged , Aged, 80 and over , Anxiety Disorders/diagnosis , COVID-19/mortality , Delirium/diagnosis , Depressive Disorder/diagnosis , Female , Hospital Mortality , Hospitalization , Humans , Inpatients , Male , Middle Aged , Referral and Consultation , Retrospective Studies , Treatment Outcome
2.
Turk J Gastroenterol ; 33(5): 387-396, 2022 05.
Article in English | MEDLINE | ID: covidwho-1893198

ABSTRACT

BACKGROUND: Coronavirus disease 2019 pandemic was expected to have traumatic effects and increase the anxiety levels of inflamma- tory bowel disease patients. METHODS: We aimed to investigate the psychosocial effects of the coronavirus disease 2019 pandemic on patients with inflammatory bowel disease by revealing the risk perception for present disease, coping strategies, follow-up characteristics, and treatment adher- ence. This is a cross-sectional, web-based survey study including 798 inflammatory bowel disease patients who were followed at our outpatient clinic and 303 volunteer who did not have any known chronic diseases and were not health professionals were included as the control group. RESULTS: In this study, 281 of the patients were diagnosed with Crohn's disease and 215 with ulcerative colitis. The mean age of patients with Crohn's disease, ulcerative colitis, and the control group were 40.9 ± 13.1, 42.3 ± 12.7, and 39.9 ± 11.6, respectively. Here, 119 (42%) of the Crohn's disease cases, 116 (54%) of the ulcerative colitis cases, and 170 (56%) of the control group were male. Among the 3 groups, coronavirus disease 2019-related post-traumatic stress disorder rates (Impact of Event Scale-Revised > 33) and State-Trait Anxiety Inventory of current status of anxiety-related anxiety rates were not statistically different while State-Trait Anxiety Inventory of anxiety tendency-related constant anxiety was higher in inflammatory bowel disease patients than the control group (P < .017). CONCLUSION: Inflammatory bowel disease patients with anxiety have a lower quality of life, and this may worsen the clinical course of the disease. Coronavirus disease 2019 is a major source of stress for such a vulnerable population. During the pandemic, psychological support and mental health awareness should be made accessible to all individuals.


Subject(s)
COVID-19 , Colitis, Ulcerative , Crohn Disease , Inflammatory Bowel Diseases , COVID-19/epidemiology , Chronic Disease , Colitis, Ulcerative/psychology , Crohn Disease/complications , Crohn Disease/psychology , Cross-Sectional Studies , Female , Humans , Inflammatory Bowel Diseases/epidemiology , Inflammatory Bowel Diseases/psychology , Male , Pandemics , Quality of Life
3.
Eskişehir Türk Dünyası Uygulama ve Araştırma Merkezi Halk Sağlığı Dergisi ; 5:108-114, 2020.
Article in Turkish | ProQuest Central | ID: covidwho-1573145

ABSTRACT

COVID-19 salgını ile mücadele kapsamında hastalığın yayılımını önlemek amacıyla iş yerlerinin, eğitim kurumlarının, kültür ve eğlence mekanlarının geçici olarak kapatılması, işyerinin çalışanlarını evden çalışmaya teşvik etmesi gibi biri dizi önlemler alındı. Hastalıktan kaynaklanan korkunun yansıra sosyal izolasyon, geleceğe ilişkin belirsizlik ve finansal sıkıntılar, tüm dünyadaki insanların yaşadığı stres ve kaygıyı artırdı. COVID-19 salgını gibi krizlerde toplumlar stres ve kaygıyı azaltmak ve depresyonu hafifletmek için teknolojiyi daha aktif kullanmaktadırlar. Teknoloji büyük insan gruplarının evden çalışmasını sağlarken, bu süreçte sosyalleşmenin ana aracı olmuştur. Teknoloji ihtiyaç duyulan eğlenceyi sağlarken, bilinçsiz bireyler sorunlu kullanım kalıpları geliştirme riski altındadır. Bu derlemenin amacı teknoloji kullanımı risklerini tartışmak ve etkilerini azaltmaya yardımcı olabilecek bazı pratik öneriler sunmaktır.Alternate : In order to prevent the spread of the disease within the scope of combating the COVID-19 epidemic, several measures were taken such as temporary closure of workplaces, educational institutions, cultural and entertainment venues, and encouraging for employees working from home. Social isolation, future uncertainty, and financial difficulties as well as fear of illness have increased stress and anxiety all over the world. In crises such as the COVID-19 outbreak, societies use technology more actively to reduce stress, anxiety, and depression. While technology enables large groups of people to work from home, it has been the main tool of socializing in this process. While technology provides the entertainment needed, unconscious individuals are at risk of developing problematic usage patterns. The aim of this review is to discuss technology use risks and provide some practical suggestions that can help reduce technology impact.

4.
J Sex Marital Ther ; 48(4): 415-426, 2022.
Article in English | MEDLINE | ID: covidwho-1528058

ABSTRACT

Based on the possible effects of androgens on the course of COVID-19, it can be posited that Gender-Affirming Hormone Therapy (GAHT) may affect the course of the disease in people with GD. We aimed to investigate the relationship between GAHT and contracting COVID-19, as well as the severity of the disease in individuals with Gender Dysphoria (GD). The single center, cross-sectional, web-based survey was completed by people with GD who received GAHT. The questionnaire contained three parts: a sociodemographic data form; a GAHT data form; a COVID-19-related data form. Of the 238 participants, 179 were individuals with female-to-male (FtM) and 59 male-to-female (MtF) GD. We detected that the risk of contracting COVID-19 increased 3.46 times in people with FtM GD, who had received testosterone therapy, in comparison to people with MtF GD, who received estrogen and anti-androgen therapy. Additionally, people with FtM GD who contracted COVID-19 had received longer testosterone therapy when compared to those who did not contract COVID-19. Our findings indicate that individuals with FtM GD who receive testosterone treatment within the scope of GAHT are at higher risk of contracting COVID-19 and that the clinicians who follow-up on GAHT should be more careful about this issue.


Subject(s)
COVID-19 Drug Treatment , COVID-19 , Gender Dysphoria , Transgender Persons , COVID-19/epidemiology , Cross-Sectional Studies , Female , Gender Dysphoria/therapy , Humans , Male , Testosterone/therapeutic use
5.
Blood Purif ; 51(5): 458-463, 2022.
Article in English | MEDLINE | ID: covidwho-1367500

ABSTRACT

INTRODUCTION: There are many differences between hemodialysis (HD) and peritoneal dialysis (PD) treatments, including their impact on the psychological status of the patients. In this study, our aim was to compare the psychological statuses of HD and PD patients during the social isolation period due to the COVID-19 pandemic. METHODS: We conducted this cross-sectional study on adult HD and PD patients when the curfew measures were in effect. We used an electronic form composed of 3 sections to collect data. In the first section, we collected data on the demographics and clinical and laboratory parameters of the patients. The second and third sections consisted of the Hospital Anxiety and Depression Scale (HADS) and the Impact of Event Scale-Revised (IES-R) questionnaires, respectively. RESULTS: The HD (n = 116) and PD (n = 130) groups were similar regarding age and sex, and they had similar HADS anxiety scores. HADS depression scores were higher in PD patients (p = 0.052). IES-R scores were significantly higher in PD patients in comparison to HD patients (p = 0.001). Frequencies of abnormal HADS-anxiety (p = 0.035) and severe psychological impact (p = 0.001) were significantly higher in PD patients. DISCUSSION/CONCLUSION: During the social isolation period due to the COVID-19 pandemic, HD patients had better mood profiles than PD patients. A more stable daily routine, an uninterrupted face-to-face contact with health-care workers, and social support among patients in the in-center dialysis environment might be the cause of the favorable mood status. PD patients might need additional psychological support during those periods.


Subject(s)
COVID-19 , Kidney Failure, Chronic , Peritoneal Dialysis , Adult , COVID-19/epidemiology , Cross-Sectional Studies , Female , Humans , Kidney Failure, Chronic/psychology , Kidney Failure, Chronic/therapy , Male , Pandemics , Peritoneal Dialysis/psychology , Quality of Life , Renal Dialysis/psychology
6.
Pituitary ; 24(4): 589-599, 2021 Aug.
Article in English | MEDLINE | ID: covidwho-1118254

ABSTRACT

PURPOSE: Patients with acromegaly and Cushing's disease (CD) may experience significant problems related to the COVID-19 outbreak. We aimed to investigate the psychosocial effects of the pandemic and reveal the follow-up characteristics. METHODS: The single center, cross-sectional, web-based survey study included patients with acromegaly and CD, PCR-confirmed COVID-19 patients and healthy volunteers without known any chronic disease. The semi-structured sociodemographic data form, The State-Trait Anxiety Inventory (STAI) and Impact of Event Scale-Revised (IES-R) were used. RESULTS: We examined 583 people (217 acromegaly, 127 CD, 102 PCR-confirmed COVID-19 patients and 137 healthy controls). The frequency of abnormal state anxiety and post-traumatic stress disorder (PTSD) were similar in patients with acromegaly and CD and healthy controls, and higher in PCR-confirmed COVID-19 patients than in these three groups (p < 0.001 for both). The frequency of abnormal trait anxiety was higher in patients with acromegaly and PCR-confirmed COVID-19 compared to patients with CD and healthy controls (p = 0.027, p < 0.001, respectively). There were no significant differences between the acromegaly and CD groups in terms of follow-up characteristics and perception of the severity of the COVID-19 outbreak (p > 0.05 for all). But, the treatment discontinuation rate was higher in patients with acromegaly than CD (p = 0.012). CONCLUSIONS: Our findings indicate that acromegaly and CD patients are psychologically less affected than PCR-confirmed COVID-19 patients and exhibit similar findings the general population. The clinicians should consider the psychosocial effects, as well as focus on the regular follow-up and medical treatments of these patients during the outbreak.


Subject(s)
Acromegaly/psychology , Anxiety/psychology , COVID-19/psychology , Pituitary ACTH Hypersecretion/psychology , Stress Disorders, Post-Traumatic/psychology , Acromegaly/diagnosis , Acromegaly/epidemiology , Adult , Anxiety/diagnosis , Anxiety/epidemiology , COVID-19/diagnosis , COVID-19/epidemiology , Case-Control Studies , Cross-Sectional Studies , Female , Health Surveys , Humans , Male , Middle Aged , Pituitary ACTH Hypersecretion/diagnosis , Pituitary ACTH Hypersecretion/epidemiology , Stress Disorders, Post-Traumatic/diagnosis , Stress Disorders, Post-Traumatic/epidemiology , Turkey/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL